News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Conference News ACC 2019 PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital Michael O'Riordan March 25, 2019